pentobarbital will decrease the level or outcome of diazepam intranasal by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Observe. Robust or average CYP3A4 inducers could boost fee of diazepam elimination; for that reason, efficacy of diazepam may be lowered.
pentobarbital will lower the extent or outcome of meloxicam by affecting hepatic enzyme CYP2C9/10 metabolism. Small/Importance Unknown.
pentobarbital will reduce the level or effect of lorlatinib by affecting hepatic/intestinal enzyme CYP3A4 metabolism.
pentobarbital will reduce the level or influence of alprazolam by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Monitor.
Estradiol valerate/dienogest shouldn't be used for a minimum of 28 days immediately after discontinuation of the inducer because of probability of reduced contraceptive efficacy.
Watch Intently (one)pentobarbital will lower the extent or effect of mifepristone by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Use Warning/Keep an eye on. CYP3A4 inducers have not been examined, coadministration not recommended by company
fentanyl transdermal and pentobarbital both of those enhance sedation. Avoid or Use Alternate Drug. Restrict use to sufferers for whom alternative cure alternatives are insufficient
Reserve concomitant prescribing of these drugs in sufferers for whom other treatment selections are insufficient. Limit dosages and durations to your minimal needed. Watch closely for signs of respiratory despair and sedation.
pentobarbital will minimize the level or impact of budesonide by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Watch.
pentobarbital will lessen the level or influence of aprepitant by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Keep track of.
pentobarbital will lessen the extent or result of atazanavir by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Minimal/Significance Not known.
Check Intently (1)pentobarbital will click here lessen the level or result of glecaprevir/pibrentasvir by influencing hepatic/intestinal enzyme CYP3A4 metabolism.
Coadministration of zuranolone with other CNS depressants could boost impairment of psychomotor functionality or CNS depressant effects. If unavoidable, look at dose reduction. .
pentobarbital will lessen the level or effect of isavuconazonium sulfate by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Contraindicated.